Advances and challenges in chimeric antigen receptor-natural killer cell immunotherapy for cancer

被引：0
|
作者：
Rafei, Hind [1 ]
Rezvani, Katayoun [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Dept Stem Cell Transplantat & Cellular Therapy, Houston, TX 77030 USA
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2025年 / 206卷 / 02期
基金：
美国国家卫生研究院;
关键词：
CAR-NK; immunotherapy; NK cells;
D O I：
10.1111/bjh.19939
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Chimeric antigen receptor (CAR)-natural killer (NK)-cell therapy has emerged as a promising strategy in the treatment of haematological malignancies and solid cancers. Leveraging the innate immune properties of NK cells, CAR-NK-cell therapies offer potential advantages for cell therapy, including safety of use in the allogeneic setting and reduced risk of toxicity. This Nutshell provides an overview of the latest advancements in CAR-NK-cell therapy and the challenges that remain.
引用
收藏
页码：443 / 446
页数：4
相关论文
共 50 条
  • [1] Engineering chimeric antigen receptor-natural killer cells for cancer immunotherapy
    Zhao, Yu
    Zhou, Xiaorong
    IMMUNOTHERAPY, 2020, 12 (09) : 653 - 664
  • [2] Chimeric Antigen Receptor-Natural Killer Cells: The Future of Cancer Immunotherapy
    Habib, Sana
    Tariq, Syed M.
    Tariq, Moeez
    OCHSNER JOURNAL, 2019, 19 (03): : 186 - 187
  • [3] The Next Generation of Cellular Immunotherapy: Chimeric Antigen Receptor-Natural Killer Cells
    Moscarelli, Jake
    Zahavi, David
    Maynard, Rachael
    Weiner, Louis M.
    TRANSPLANTATION AND CELLULAR THERAPY, 2022, 28 (10): : 650 - 656
  • [4] Chimeric antigen receptor-natural killer cell therapy: current advancements and strategies to overcome challenges
    Kong, Jun Chang
    Sa'ad, Mohammad Auwal
    Vijayan, Hema Manusri
    Ravichandran, Manickam
    Balakrishnan, Venugopal
    Tham, Seng Kong
    Tye, Gee Jun
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [5] Chimeric antigen receptor-natural killer cells: Novel insight into immunotherapy for solid tumors (Review)
    Peng, Xiaobo
    Chen, Ling
    Chen, Longpei
    Wang, Bin
    Wang, Yiran
    Zhan, Xianbao
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2021, 21 (04)
  • [6] Chimeric antigen receptor-natural killer (CAR-NK) cell immunotherapy: A bibliometric analysis from 2004 to 2023
    Li, Wangshu
    Feng, Jiuxiang
    Peng, Jianan
    Zhang, Xu
    Aziz, Aziz Ur Rehman
    Wang, Daqing
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2024, 20 (01)
  • [7] Reformation in chimeric antigen receptor based cancer immunotherapy: Redirecting natural killer cell
    Lin, Chu
    Zhang, Jun
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2018, 1869 (02): : 200 - 215
  • [8] Chimeric Antigen Receptor Expressing Natural Killer Cells for the Immunotherapy of Cancer
    Mehta, Rohtesh S.
    Rezvani, Katayoun
    FRONTIERS IN IMMUNOLOGY, 2018, 9
  • [9] Chimeric antigen receptor armored natural killer cell immunotherapy for osteosarcoma
    Robbins, Gabrielle
    Yamomoto, Kenta
    Lahr, Walker
    Skeate, Joseph
    CLINICAL CANCER RESEARCH, 2022, 28 (18)
  • [10] Advancement of chimeric antigen receptor-natural killer cells targeting hepatocellular carcinoma
    Dai, Kai
    Wu, Yin
    She, Sha
    Zhang, Qian
    WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2021, 13 (12) : 2029 - 2037
12345